Boehringer expands production site in Greece for new medicine
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of
POSTS IN CATEGORY
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of
A liquid compression system prototype at General Fusion’s Canadian labs RICHMOND, British Columbia, Jan. 11,
REGENETEN Patch 2024 First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for
Quantexa to provide category-leading AI-enabled technology, training, and industry expertise to ATII to improve how